Publications by authors named "Patrick A Candy"

Claim this Profile
M
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression.
Michael R Epis, Keith M Giles, Dianne J Beveridge, Kirsty L Richardson, Patrick A Candy

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Keith M Giles, Rikki A M Brown, Clarissa Ganda, Melissa J Podgorny, Patrick A Candy

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-331-3p regulates expression of neuropilin-2 in glioblastoma.
Michael R Epis, Keith M Giles, Patrick A Candy, Rebecca J Webster, Peter J Leedman

J Neurooncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
Keith M Giles, Felicity C Kalinowski, Patrick A Candy, Michael R Epis, Priscilla M Zhang

Mol Cancer Ther· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7.
Felicity C Kalinowski, Keith M Giles, Patrick A Candy, Alishum Ali, Clarissa Ganda

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis